Pharmacodynamic analysis of steroid 5α-reductase inhibitory actions of Z-350 in rat prostate-Reference-Cited by-同舟云学术

Pharmacodynamic analysis of steroid 5α-reductase inhibitory actions of Z-350 in rat prostate

Published:2001-08 Issue:1-2 Volume:426 Page:105-111
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Furuta Shigeru,Fukuda Youich,Sugimoto Tohru,Miyahara Haruka,Kamada Emiko,Sano Hiroshi,Fukuta Yoshihisa,Takei Mineo,Kurimoto Tadashi

Publisher

Elsevier BV

Subject

Pharmacology

Reference19 articles.

1. The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia;Craig;N. Engl. J. Med.,1987

2. Pharmacological properties of Z-350, which processes α1-adenoceptor antagonistic and steroid 5α-reductase inhibitory actions; (1) in vitro studies;Fukuda;Jpn. J. Pharmacol.,1998

3. Z-350, a new chimera compound possessing α1-adenoceptor antagonistic and steroid 5α-reductase inhibitory actions;Fukuda;Naunyn-Schmiedeberg's Arch Pharmacol.,1999

4. Hormonal effects of Z-350, possessing 5α-reductase inhibitory and α1-adenoceptor antagonistic in the rat;Fukuda;Jpn. J. Pharmacol.,2001

5. Pharmacological properties of Z-350, which processes α1-adenoceptor antagonistic and steroid 5α-reductase inhibitory actions; (2) in vivo studies;Fukuta;Jpn. J. Pharmacol.,1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzyme Inhibition and Inactivation;The Organic Chemistry of Drug Design and Drug Action;2014

2. Steroid 5-α reductase type 2 activity in biopsies from malignant and normal prostatic tissues;Clinica Chimica Acta;2008-05

3. Enzyme Inhibition and Inactivation;The Organic Chemistry of Drug Design and Drug Action;2004